MR imaging has been established as the most important tool for diagnosing multiple sclerosis (MS). In addition, this modality is increasingly being used to monitor disease activity, disease progression and therapeutic effects, and is therefore now recognized as an “imaging biomarker” for MS. Furthermore, MR imaging is also useful for diagnosing the side effects of pharmacotherapies. This lecture focuses on the role of MR imaging in the diagnosis and management in MS.
This abstract and the presentation materials are available to members only; a login is required.